Willuweit, K.; Frey, A.; Passenberg, M.; Korth, J.; Saka, N.; Anastasiou, O.E.; Möhlendick, B.; Schütte, A.; Schmidt, H.; Rashidi-Alavijeh, J.
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers. Vaccines 2022, 10, 377.
https://doi.org/10.3390/vaccines10030377
AMA Style
Willuweit K, Frey A, Passenberg M, Korth J, Saka N, Anastasiou OE, Möhlendick B, Schütte A, Schmidt H, Rashidi-Alavijeh J.
Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers. Vaccines. 2022; 10(3):377.
https://doi.org/10.3390/vaccines10030377
Chicago/Turabian Style
Willuweit, Katharina, Alexandra Frey, Moritz Passenberg, Johannes Korth, Nissrin Saka, Olympia E. Anastasiou, Birte Möhlendick, Andreas Schütte, Hartmut Schmidt, and Jassin Rashidi-Alavijeh.
2022. "Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers" Vaccines 10, no. 3: 377.
https://doi.org/10.3390/vaccines10030377
APA Style
Willuweit, K., Frey, A., Passenberg, M., Korth, J., Saka, N., Anastasiou, O. E., Möhlendick, B., Schütte, A., Schmidt, H., & Rashidi-Alavijeh, J.
(2022). Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers. Vaccines, 10(3), 377.
https://doi.org/10.3390/vaccines10030377
